Fudan University: all 1,308 studies
Page 9 of 14. Open to participants first (637), then studies with results posted, then the rest; newest registration first within each.
- Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib for Patients with Advanced Pancreatic CancerCompletedNCT05303090Phase 1
- Cryoablation Combined With Tirelizumab and Bevacizumab in Liver Metastatic TNBC Patients Failed by Multiline TherapyStatus unknownNCT05303038Phase 2
- Serratus Anterior Plane Block for Modified Radical Mastectomy: Double-point VS Single-pointCompletedNCT05299021Not applicable
- Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or CarcinosarcomaStatus unknownNCT05265793Phase 2
- A Phase II Clinical Trial of Fruquintinib as Third Line Treatment in Advanced Pancreatic CancerStatus unknownNCT05257122Phase 2
- Efficacy and Safety of Furmonertinib in EGFR-Mutant, PD-L1+ Patients With Locally Advanced or Metastatic NSCLC (FUTURE)Status unknownNCT05255406Phase 2
- Capecitabine Combined With Lenvatinib and Tislelizumab as Adjuvant Treatment After Resection in Patients With BTCCompletedNCT05254847Phase 2
- Evaluation of Correlations Between Radiologic Features and Pathologic Subtypes of GGO LUAD Via WMS (ECTOP-1011)CompletedNCT05252676
- Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial CancerActive, not recruitingNCT05247268Phase 2
- Fluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST TrialActive, not recruitingNCT05223582Phase 2
- DDP ip Combined With AG in PDAC With Peritoneal MetastasisCompletedNCT05222204Phase 2
- Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate CancerStatus unknownNCT05212857Phase 2
- Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal CancerStatus unknownNCT05193292Phase 2
- The Effect of Intervention With Probiotic K56 on Body Fat Reduction in Obese SubjectsStatus unknownNCT05192811Not applicable
- Circulating EV Long RNA Profiles in SCLCStatus unknownNCT05191849Not applicable
- A Study to Evaluate Efficacy and Safety of Zanubrutinib With R-CHOP in Newly Diagnosed Non-GCB DLBCL Patients With Double ExpressionActive, not recruitingNCT05189197Phase 2
- Analysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA TrialStatus unknownNCT05188911
- Tislelizumab Combined With Sitravatinib as Consolidation Treatment Following Concurrent Chemoradiation in Patients With Locally Advanced, Unresectable NSCLCTerminatedNCT05176925Phase 2
- Induction of Cisplatin/Nab-paclitaxel/Pembrolizumab Followed by Olaparib/Pembrolizumab Maintenance in mTNBC PatientsStatus unknownNCT05174832Phase 2
- Loxenatide Plus LNG-IUS in Endometrial Atypical HyperplasiaCompletedNCT05172999Phase 2/3
- The First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer PatientsStatus unknownNCT05168527Phase 2
- Value of ctDNA in the Treatment of Multiple Primary CancersStatus unknownNCT05164510Phase 2
- Evaluation of Circulating Tumor DNA Guided Surveillance Strategy of Stage III Colorectal Cancer: an Open, Prospective, Randomized Controlled Cohort StudyStatus unknownNCT05161585Not applicable
- Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric CancerTerminatedNCT05161572Phase 2
- Clinical Phenotype and Omics Study of KCNQ2-related EpilepsyStatus unknownNCT05157737
- Titration of Intraoperative PEEP in Patients Undergoing Robotic Assisted Laparoscopic ProstatectomyCompletedNCT05155371Not applicable
- Real-world Experience of ICIs Plus Chemotherapy for Advanced ESCC.CompletedNCT05142709
- Fruquintinib in the Treatment of Soft Tissue SarcomaStatus unknownNCT05142631Phase 2
- Axillary Sentinel or Targeted Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy in Node-positive Breast CancerStatus unknownNCT05141630Phase 2
- A Study of Donafenib Plus S-1 in Treating Patients With Metastatic Pancreatic Cancer After Chemotherapy With Nab-paclitaxel Plus Gemcitabine RegimenStatus unknownNCT05138159Phase 2
- NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid TumorsStatus unknownNCT05131763Phase 1
- Anlotinib Plus Everolimus as First-line Treatment for Advanced Non Clear Cell Renal Cell CarcinomaStatus unknownNCT05124431Phase 2
- RWE About QOL and Compliance of Patients With OFS in ChinaCompletedNCT05122377
- Camrelizumab Plus Pyrotinib Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaStatus unknownNCT05111444Phase 2
- Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric CancerStatus unknownNCT05095636Phase 2
- A Cohort of Molecular Characteristics and Prognosis of Colorectal CancerStatus unknownNCT05086601
- Neoadjuvant With Trastuzumab, Pyrotinib Plus Palbociclib and Fulvestrant in HER2-positive, ER-positive Breast CancerStatus unknownNCT05076695Phase 2
- Tenofovir Alafenamide for HBV Prophylaxis in Post Orthotopic Liver TransplantStatus unknownNCT05063071Phase 4
- GP Chemotherapy in Combination With Tislelizumab and Ociperlimab as First-line Treatment in Advanced BTCWithdrawnNCT05019677Phase 2
- ARX788 in HER2-positive Breast Cancer Patients With Brain MetastasesStatus unknownNCT05018702Phase 2
- ARX788 in Breast Cancer With Low Expression of HER2Status unknownNCT05018676Phase 2
- Health Benefits of Air Purifiers in Primary School StudentsActive, not recruitingNCT05016271Not applicable
- Cryoablation Combined with Sintilimab Plus Lenvatinib in Patients with Advanced Intrahepatic CholangiocarcinomaCompletedNCT05010668Phase 2
- Tislelizumab in the Systematic Treatment of Advanced Hepatocellular CarcinomaStatus unknownNCT04996459
- ALPPS Combined With Tislelizumab in Liver MalignancyStatus unknownNCT04996446Phase 2
- Prediction of 18F-FES-PET/CT Parameters on Palbociclib Combined With ETCompletedNCT04992156
- Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab in Unresectable Biliary Tract CancerStatus unknownNCT04984980Phase 2
- Research on Risk Factors and Interventions of Polycystic Ovary Syndrome Complicated With Depression and AnxietyStatus unknownNCT04984070Not applicable
- Effect of a Probiotic Strain Lactobacillus Paracasei K56 on Metabolic Symptom - a Pilot StudyCompletedNCT04980599Not applicable
- GEMOX Combined With Donafenib and Tislelizumab in Biliary Tract CancerStatus unknownNCT04979663Phase 1/2
- PD-1 Antibody and Lenvatinib Plus TACE on Downstaging BCLC B/C HCCStatus unknownNCT04974281Early Phase 1
- Efficacy and Safety of Pyrotinib in HER2 Positive Gastrointestinal TumorsStatus unknownNCT04960943Phase 2
- TACE Combined with Sintilimab Plus Bevacizumab Biosimilar in Patients with Advanced Hepatocellular Carcinoma (TASK-02)CompletedNCT04954794Phase 2
- Real World Study of Diagnosis and First-line Treatment Among Patients With Cancer of Unknown Primary in ChinaStatus unknownNCT04952103
- The Combination of Fruquintinib, Tislelizumab and Stereotactic Ablative Radiotherapy in Metastatic Colorectal Cancer(RIFLE)Status unknownNCT04948034Phase 2
- Single-cell Sequencing and Establishment of Models in Neuroendocrine NeoplasmStatus unknownNCT04927611
- Immunotherapy and Chemotherapy in Unresectable Recurrent Loco-regionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT04921995Phase 2
- Tislelizumab in Combination With Eribulin for Patients With Metastatic Previously heaviLy-treAted TriplE-negative Breast Cancer：A Prospective Multiple-center Phase II StudyStatus unknownNCT04913571Phase 2
- Granisetron Transdermal Patch for Prophylaxis of Delayed CINVStatus unknownNCT04912271Phase 3
- Preoperative Irinotecan Drug-eluting Beads for Patients With Unresectable Colorectal Liver MetastasisStatus unknownNCT04912258Phase 3
- PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale Cancers, PERCEIVE-IStatus unknownNCT04903665
- A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical ResectionStatus unknownNCT04856761
- Pyrotinib Plus Vinorelbine Versus Lapatinib Plus CapecitabineCompletedNCT04850625
- PD-1 Inhibitor and Nab-paclitaxel and Bevacizumab in CUPStatus unknownNCT04848597Phase 2
- Sintilimab Combined With Bevacizumab Biosimilar for Potentially Resectable Intermediate HCCStatus unknownNCT04843943Phase 1/2
- cTACE Plus Sintilimab for Unresectable Intermediate-stage HCC With Beyond Up-to-seven CriteriaCompletedNCT04842565Phase 2
- Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy.Status unknownNCT04835064Phase 3
- c-CetuIRI Versus Ersecond-line Irinotecan s-IRI-CetuIRIStatus unknownNCT04833036Phase 2
- Gene Abnormalities and Prognosis in Diffuse Large B-cell LymphomaStatus unknownNCT04825899
- Adjuvant PD-1 Antibody in Combination With Capecitabine for Patients With ICC at High-Risk of Postoperative RecurrenceStatus unknownNCT04782804Phase 1/2
- Albumin-bound Paclitaxel Combination With Capecitabine Versus Capecitabine Monotherapy in Paclitaxel/Docetaxel-resistant Advanced Breast CancerStatus unknownNCT04780347Phase 2
- Intraperitoneal Injection of Oncolytic Viruses H101 for Patients With Refractory Malignant AscitesCompletedNCT04771676Phase 2
- Dynamic Observational Study With PET of 68Ga-HER2-affibody in Anti-HER2 TreatmentStatus unknownNCT04769050
- Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)Active, not recruitingNCT04764227Phase 2
- SRT for Residual Oligometastases of NSCLC After 3rd Generation EGFR-TKIsCompletedNCT04764214Phase 2
- Raltitrexed in HIPECCompletedNCT04761185Phase 1
- Study on the Value of Non-invasive Dual-Pet Information in Subtype of Metastatic Breast CancerStatus unknownNCT04758416
- Guided Treatment Based on Mini-PDX in Metastatic Triple Negative Breast CancerStatus unknownNCT04745975Phase 2
- Multi Dimensional Precise Exploration of Immunoconsolidation Therapy for Locally Advanced NSCLC After Chemo-radiotherapyStatus unknownNCT04741633
- Study on Pulmonary Rehabilitation for Stable Chronic Obstructive Pulmonary Disease(COPD) PatientsStatus unknownNCT04741373Not applicable
- A Phase II Study to Explore the Safety, Tolerability, and Preliminary Antitumor Activity of Sitravatinib Plus Tislelizumab or Combination With Nab-paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)Active, not recruitingNCT04734262Phase 2
- Ntraperitoneal Thermal Perfusion Combined With Chemotherapy Versus ChemotherapyStatus unknownNCT04707118Phase 1
- Pyrotinib Combined With Pemetrexed Plus Carboplatin in the First-line TreatmentStatus unknownNCT04706949Phase 2
- Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG TreatmentActive, not recruitingNCT04706598Phase 1/2
- Genomic Study of Relapse Esophageal Cancer After RadiotherapyStatus unknownNCT04694391
- Prepectoral and Subpectoral Implant-based Breast ReconstructionActive, not recruitingNCT04688697Not applicable
- Microwave Ablation Combined With Chemotherapy in the Treatment of Pancreatic Cancer Oligohepatic MetastasisStatus unknownNCT04677192Phase 2
- Diagnostic Accuracy of CCTA-derived Versus AngiogRaphy-dErived QuantitativE Flow Ratio (CAREER) StudyStatus unknownNCT04665817
- Clinical Efficacy and SAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary InterventionCompletedNCT04665648Phase 4
- Effect of Chewing Gum and Mouthwash Before Operation on Sore Throat After General Anesthesia With a Laryngeal MaskStatus unknownNCT04644900Not applicable
- The Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in Oligometastatic Gastrointestinal CancerStatus unknownNCT04625894Phase 1
- AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic CancerStatus unknownNCT04617821Phase 3
- Effects of One-handed and Two-handed Mask Ventilation Techniques on Global and Regional Lung VentilationStatus unknownNCT04617665Not applicable
- Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid CancerStatus unknownNCT04612894Phase 2
- Accuracy of VABB Elite 10G Versus BARD 14G CNBStatus unknownNCT04612439Phase 3
- Surgical Pleth Index: Predicting the Optimal Timing for Tracheal Intubation During General AnesthesiaStatus unknownNCT04608240
- Metformin Plus Megestrol Acetate As a Fertility-sparing Treatment in Patients with Atypical Endometrial HyperplasiaTerminatedNCT04607252Phase 2/3
- Anti-PD-1 Antibody in the Treatment of Patients With Malignant Melanoma of the Female Genital TractStatus unknownNCT04593485Phase 2
- Almonertinib/Pemetrexed/Carboplatin in EGFR T790M+ Advanced Lung CancerStatus unknownNCT04592666Phase 2
- Fruquintinib and Raltitrexed Versus Fruquintinib Monotherapy in Advanced Colorectal CancerStatus unknownNCT04582981Phase 2